Answers are grounded in this paper and cite their sources.
Peptide nucleic acids (PNA) are synthetic nucleic acid mimics in which the negatively charged sugar-phosphate backbone of DNA and RNA is replaced by a neutral pseudopeptide backbone. This neutral backbone reduces dependence on ionic strength, provides resistance to protease and nuclease degradation, and promotes high-affinity binding to complementary nucleic acids. Modification at the γ-carbon of the backbone can further improve solubility, reduce aggregation, and preorganize the backbone into a chiral helical conformation. However, the steric demands of γ-modified PNA (γPNA) monomers, together with on-resin aggregation and base-mediated side reactions, make γPNA difficult to synthesize efficiently. Here, we report an automated flow microscale synthesis (AFMS) platform for rapid preparation of N-(2-aminoethyl)glycine PNA (aegPNA), L-serine γPNA (LS-γPNA), and hybrid PNA (hPNA). Independent control of coupling and deprotection temperatures enabled rapid amide-bond formation in 10 s while limiting base-mediated degradation and provided access to long PNA sequences with high fidelity and high purity. Preparative strong cation-exchange chromatography further isolated target PNA from side products unresolved by reverse-phase high performance-liquid chromatography. This synthesis-to-function workflow enabled evaluation of how LS-γPNA content and distribution influence RNA recognition. Unexpectedly, increasing γPNA incorporation enhanced duplex thermal stability while progressively reducing intracellular splice-correction activity, revealing that productive RNA targeting requires a balance between backbone preorganization, conformational adaptability, and target-engagement kinetics.
No takes yet. Share an insight, caveat, or question.
Sarabia-Castillo et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: